Smartphone-Based Proactive Self-Screening for Ocular Surface Malignancies: A Nonrandomized Clinical Trial - Report - MDSpire

Mobile Device-Enabled Proactive Self-Assessment for Ocular Surface Cancers: A Nonrandomized Clinical Investigation

  • By

  • Ruixin Wang

  • Shaowei Bi

  • Duoru Lin

  • Mingyuan Li

  • Lanqin Zhao

  • Yukun Zhou

  • Ling Jin

  • Wenben Chen

  • Ruiyang Li

  • Yuanjun Shang

  • Huasheng Yang

  • Rongxin Chen

  • Wei Xiao

  • Siming Ai

  • Jianbing Li

  • Shiqi Ling

  • Xiaohang Wu

  • Zhixiong Li

  • Guiqin Liu

  • Yinyue Lu

  • Wen Lin

  • Huiying Rao

  • Xiangda Meng

  • Hua Yan

  • Cong Nie

  • Min Zhu

  • Huijing Ye

  • Haotian Lin

  • July 1, 2026

Share

Clinical Report: Mobile Device-Enabled Proactive Self-Assessment for Ocular Surface Cancers

Overview

This study presents CaptureTumor (CaT), an AI-driven smartphone application designed for the early detection of ocular surface tumors. The system integrates public education and self-screening.

Background

Ocular surface cancers are often misdiagnosed due to public misconceptions and limited specialist availability, leading to advanced disease at diagnosis. Early detection is crucial to prevent severe outcomes, including vision loss and life-threatening metastasis.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • CaptureTumor (CaT) is an AI-driven diagnostic system for smartphone deployment.
  • The study involved a three-stage process: model training, adaptation for smartphone use, and real-world implementation.
  • Public education and AI-facilitated self-screening are integrated into the CaT system.
  • The system aims to enhance timely access to specialist care for ocular surface tumors.

Clinical Implications

The integration of mobile health platforms like CaT could facilitate earlier detection of ocular surface tumors.

Conclusion

The development of the CaptureTumor application represents a significant step towards enhancing the early detection of ocular surface cancers through innovative technology.

Related Resources & Content

  1. JAMA Ophthalmology, 2023 -- Smartphone-Based Proactive Self-Screening for Ocular Surface Malignancies
  2. The Ophthalmologist, 2026 -- Smartphones Spot Ocular Malignancies
  3. Retinal Physician, 2023 -- Clinical Trial Update October 2023
  4. Retinal Physician — CLINICAL TRIAL UPDATE
  5. Retinal Physician — Clinical Trial Update November/December 2023
  6. https://www.rcpath.org/static/d59407d8-310c-46ec-b1c6242f948b74ad/283c3274-9230-462c-ad4d9379d7652b1f/G054-dataset-for-histopathological-reporting-of-conjunctival-melanoma.pdf
  7. Metastatic conjunctival melanoma: a multicentre international study - PubMed
  8. Smartphone-Based Proactive Self-Screening for Ocular Surface Malignancies: A Nonrandomized Clinical Trial | Trials | JAMA Ophthalmology | JAMA Network

Original Source(s)

Smartphone-Based Proactive Self-Screening for Ocular Surface Malignancies: A Nonrandomized Clinical Trial

  • by Ruixin Wang, Shaowei Bi, Duoru Lin, Mingyuan Li, Lanqin Zhao, Yukun Zhou, Ling Jin, Wenben Chen, Ruiyang Li, Yuanjun Shang, Huasheng Yang, Rongxin Chen, Wei Xiao, Siming Ai, Jianbing Li, Shiqi Ling, Xiaohang Wu, Zhixiong Li, Guiqin Liu, Yinyue Lu, Wen Lin, Huiying Rao, Xiangda Meng, Hua Yan, Cong Nie, Min Zhu, Huijing Ye, Haotian Lin

  • July 1, 2026

Related Content

Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something?

SMARCB1 (INI1)-deficient malignant melanocytic neoplasm with histologically confirmed vertebral metastases in a young adult: a case report

Clinical features and treatment challenges of HER2-positive primary breast squamous cell carcinoma: a case report and literature review